Kawahara Y, Matsumura K, Hashimoto T, Nishikawa T
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
Acta Derm Venereol. 1997 May;77(3):187-90. doi: 10.2340/0001555577187190.
We analyzed circulating antibodies in sera from patients with localized pemphigoid and pemphigoid nodularis, two variants of bullous pemphigoid, by means of western immunoblotting of human epidermal extracts and the recombinant protein of NC16a domain of the 180 kD bullous pemphigoid antigen. NC16a domain is now considered to be the most pathogenic site of bullous pemphigoid. Compared with the results of typical bullous pemphigoid patients, localized pemphigoid sera detected the 180 kD bullous pemphigoid antigen less frequently, and sera from both localized pemphigoid and pemphigoid nodularis showed a lower end point of titer of antibodies to NC16a domain. These results suggest that atypical clinical features of the two bullous pemphigoid variants may be related with low titer of autoantibodies to 180 kD bullous pemphigoid antigen, particularly to NC16a domain.
我们通过对人表皮提取物和180kD大疱性类天疱疮抗原NC16a结构域的重组蛋白进行蛋白质免疫印迹分析,检测了局限性类天疱疮和结节性类天疱疮(大疱性类天疱疮的两种变体)患者血清中的循环抗体。NC16a结构域目前被认为是大疱性类天疱疮最具致病性的位点。与典型大疱性类天疱疮患者的结果相比,局限性类天疱疮血清检测到180kD大疱性类天疱疮抗原的频率较低,局限性类天疱疮和结节性类天疱疮的血清对NC16a结构域的抗体滴度终点均较低。这些结果表明,这两种大疱性类天疱疮变体的非典型临床特征可能与针对180kD大疱性类天疱疮抗原,特别是针对NC16a结构域的自身抗体滴度较低有关。